Konrad E Bloch Selected Research

AT 760

1/2020	Right-to-left shunts in lowlanders with COPD traveling to altitude: a randomized controlled trial with dexamethasone.
1/2020	Validation of a Portable Blood Gas Analyzer for Use in Challenging Field Conditions at High Altitude.
1/2019	Effect of Dexamethasone on Nocturnal Oxygenation in Lowlanders With Chronic Obstructive Pulmonary Disease Traveling to 3100 Meters: A Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konrad E Bloch Research Topics

Disease

18	Pulmonary Hypertension 01/2022 - 01/2006
18	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 12/2014
15	Hypoxia (Hypoxemia) 01/2022 - 02/2009
12	Sleep Apnea Syndromes (Sleep Apnea) 01/2020 - 12/2003
9	Obstructive Sleep Apnea 01/2021 - 12/2003
8	Emphysema 12/2014 - 05/2002
7	Dyspnea (Shortness of Breath) 01/2021 - 05/2002
6	Apnea 01/2021 - 12/2008
6	Sleepiness 01/2020 - 03/2007
5	Hyperoxia 01/2022 - 01/2017
5	Altitude Sickness (Mountain Sickness) 10/2018 - 01/2006
4	Inflammation (Inflammations) 01/2022 - 11/2011
4	Pulmonary Edema 01/2011 - 10/2006
3	Asthma (Bronchial Asthma) 01/2022 - 07/2019
3	Heart Failure 01/2021 - 01/2012
3	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2019 - 01/2011
3	Respiratory Insufficiency (Respiratory Failure) 01/2019 - 01/2005
3	Insulin Resistance 01/2013 - 03/2007
3	Nasal Obstruction 02/2009 - 02/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2010
2	Pulmonary Emphysema 08/2018 - 01/2009
1	Congenital Heart Defects (Congenital Heart Defect) 02/2022
1	Respiratory Hypersensitivity 01/2022
1	Pulmonary Arterial Hypertension 10/2021
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2021
1	Hyperventilation 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Hyperglycemia 01/2019
1	Fibrosis (Cirrhosis) 08/2018
1	Brain Hypoxia (Cerebral Hypoxia) 01/2018
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Disease Progression 01/2017
1	Gastroparesis 01/2016
1	Lung Diseases (Lung Disease) 01/2016
1	Constipation 01/2014
1	Acidosis 01/2014
1	Polycythemia (Erythrocytosis) 04/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2013
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 09/2012
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2012
1	Retinal Hemorrhage 02/2011
1	Hemorrhage 02/2011
1	Brain Edema (Cerebral Edema) 05/2008
1	Diabetes Mellitus 03/2007

Drug/Important Bio-Agent (IBA)

35	Oxygen (Dioxygen)IBA 02/2022 - 01/2005
11	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 01/2006
10	Acetazolamide (Diamox)FDA LinkGeneric 01/2021 - 01/2011
5	GoldIBA 01/2021 - 01/2018
3	Vasodilator Agents (Vasodilators)IBA 01/2022 - 12/2014
3	GasesIBA 01/2021 - 01/2021
3	Carbon DioxideIBA 01/2021 - 09/2005
3	AT 760IBA 01/2020 - 01/2019
3	Pharmaceutical PreparationsIBA 10/2018 - 12/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 08/2009
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2017
2	prednylidene (Pred)IBA 01/2021 - 01/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2020 - 10/2006
2	Hemoglobins (Hemoglobin)IBA 08/2014 - 04/2013
2	LipidsIBA 01/2013 - 11/2011
2	Retinaldehyde (Retinal)IBA 02/2011 - 02/2009
2	Tadalafil (Cialis)FDA Link 08/2009 - 10/2006
1	Biological ProductsIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Immunoglobulin E (IgE)IBA 08/2020
1	3,5-diisopropylsalicylic acid (DIPS)IBA 01/2020
1	TabletsIBA 01/2019
1	M 92 (VA 2)IBA 01/2019
1	NitrogenIBA 11/2018
1	Opioid Analgesics (Opioids)IBA 01/2017
1	goblet cell silencer inhibitorIBA 01/2016
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2016
1	ProstaglandinsIBA 12/2014
1	Endothelin Receptor AntagonistsIBA 12/2014
1	Iloprost (Ventavis)FDA Link 12/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Troponin T (Troponin T1)IBA 01/2013
1	C-Reactive ProteinIBA 01/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013
1	CytokinesIBA 01/2013
1	oxidized low density lipoproteinIBA 01/2013
1	CatecholaminesIBA 11/2011
1	APTIBA 11/2010
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 08/2009
1	xylometazoline (stas)IBA 12/2008
1	Indicators and Reagents (Reagents)IBA 05/2008
1	AcidsIBA 03/2007

Therapy/Procedure

29	Therapeutics 02/2022 - 08/2002
9	Continuous Positive Airway Pressure 01/2021 - 12/2003
8	Pneumonectomy (Lung Volume Reduction) 08/2018 - 05/2002
3	Lung Transplantation 05/2009 - 08/2002
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2017 - 01/2014
1	Intravenous Administration 01/2021
1	Breathing Exercises 07/2019
1	Noninvasive Ventilation 01/2019
1	Cannula 01/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2019
1	Decompression 08/2018
1	Aftercare (After-Treatment) 01/2018